Christopher P. Molineaux is a director of Aclaris Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aclaris Therapeutics, Inc.
6 Jun 22
4
Aclaris Therapeutics, Inc.
4 Jun 21
4
Aclaris Therapeutics, Inc.
8 Jun 20
4
Aclaris Therapeutics, Inc.
4 Mar 20
4
Aclaris Therapeutics, Inc.
10 Jun 19
4
Aclaris Therapeutics, Inc.
8 Jun 18
4
Aclaris Therapeutics, Inc.
9 Apr 18
4
Aclaris Therapeutics, Inc.
22 Mar 18
4
Aclaris Therapeutics, Inc.
16 Jun 17
4
Aclaris Therapeutics, Inc.
21 Mar 17
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jun 22 | ACRS Aclaris Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,356 | 0.00 | 27,247 |
| 3 Jun 22 | ACRS Aclaris Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,356 | 0.00 | 0 |
| 2 Jun 22 | ACRS Aclaris Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,507 | 0.00 | 4,507 |
| 2 Jun 22 | ACRS Aclaris Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.48 | 15,750 | 228.06 k | 15,750 |